IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v404y2000i6777d10.1038_35006574.html
   My bibliography  Save this article

Peptide exosite inhibitors of factor VIIa as anticoagulants

Author

Listed:
  • Mark S. Dennis

    (Genentech Inc.)

  • Charles Eigenbrot

    (Genentech Inc.)

  • Nicholas J. Skelton

    (Genentech Inc.)

  • Mark H. Ultsch

    (Genentech Inc.)

  • Lydia Santell

    (Genentech Inc.)

  • Mary A. Dwyer

    (Genentech Inc.
    University of Chicago)

  • Mark P. O'Connell

    (Genentech Inc.)

  • Robert A. Lazarus

    (Genentech Inc.)

Abstract

Potent anticoagulants have been derived by targeting the tissue factor–factor VIIa complex with naive peptide libraries displayed on M13 phage. The peptides specifically block the activation of factor X with a median inhibitory concentration of 1 nM and selectively inhibit tissue-factor-dependent clotting. The peptides do not bind to the active site of factor VIIa; rather, they work by binding to an exosite on the factor VIIa protease domain, and non-competitively inhibit activation of factor X and amidolytic activity. One such peptide (E-76) has a well defined structure in solution determined by NMR spectroscopy that is similar to the X-ray crystal structure when complexed with factor VIIa. These structural and functional studies indicate an allosteric ‘switch’ mechanism of inhibition involving an activation loop of factor VIIa and represent a new framework for developing inhibitors of serine proteases.

Suggested Citation

  • Mark S. Dennis & Charles Eigenbrot & Nicholas J. Skelton & Mark H. Ultsch & Lydia Santell & Mary A. Dwyer & Mark P. O'Connell & Robert A. Lazarus, 2000. "Peptide exosite inhibitors of factor VIIa as anticoagulants," Nature, Nature, vol. 404(6777), pages 465-470, March.
  • Handle: RePEc:nat:nature:v:404:y:2000:i:6777:d:10.1038_35006574
    DOI: 10.1038/35006574
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/35006574
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/35006574?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Stefan Gerhardy & Mark Ultsch & Wanjian Tang & Evan Green & Jeffrey K. Holden & Wei Li & Alberto Estevez & Chris Arthur & Irene Tom & Alexis Rohou & Daniel Kirchhofer, 2022. "Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:404:y:2000:i:6777:d:10.1038_35006574. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.